3-Bicyclo[3.2.1]octanyl 3-hydroxy-2-phenylpropanoate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羟基酸及其衍生物
• 英文名称: 3-Bicyclo[3.2.1]octanyl 3-hydroxy-2-phenylpropanoate
• 化学式: C₁₇H₂₂O₃
• 分子量: 274.35
• InChiKey: HHBXHTHQIDNQPQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.59
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Methods for One-Pot N-Demethylation/N-Functionalization of Morphine and Tropane Alkaloids
  申请人：Hudlicky Tomas

  公开号：US20110313163A1

  公开（公告）日：2011-12-22

  The present invention provides a method for the N-demethylation and N-functionalization of an N-methylated heterocycle such as a morphine alkaloid or tropane alkaloid. The method comprises reacting the heterocycle with an functionalization agent in the presence of a transition metal catalyst in air or in the presence of an oxidant.

  本发明提供了一种用于N-去甲基化和N-官能化的方法，该方法适用于N-甲基杂环化合物，例如吗啡生物碱或曲剪生物碱。该方法包括在过渡金属催化剂的存在下，在空气中或在氧化剂的存在下，将杂环化合物与官能化试剂反应。
• METHODS FOR ONE-POT N-DEMETHYLATION/N-FUNCTIONALIZATION OF MORPHINE AND TROPANE ALKALOIDS
  申请人：Brock University

  公开号：US20150152120A1

  公开（公告）日：2015-06-04

  The present invention provides a method for the N-demethylation and N-functionalization of an N-methylated heterocycle such as a morphine alkaloid or tropane alkaloid. The method comprises reacting the heterocycle with an functionalization agent in the presence of a transition metal catalyst in air or in the presence of an oxidant.

  本发明提供了一种对N-甲基杂环，如吗啡生物碱或曲柳生物碱进行N-脱甲基化和N-官能化的方法。该方法包括在空气中或在氧化剂存在下，将杂环与官能化试剂在过渡金属催化剂的存在下反应。
• Methods of Treating Autism
  申请人：Seaside Therapeutics, Inc.

  公开号：US20130261186A1

  公开（公告）日：2013-10-03

  Subjects having autism are treated with a composition that includes gamma-aminobutyric acid agonists. The gamma-aminobutyric acid agonist (GABA) can be a GABA(B) agonist, such as baclofen. The humans can be administered the GABA(B) agonist in a single dose or multiple doses.
• METHODS OF USING DANTROLENE TO TREAT NERVE AGENT EXPOSURE
  申请人：EAGLE PHARMACEUTICALS, INC.

  公开号：US20200383954A1

  公开（公告）日：2020-12-10

  The disclosure is directed to methods of treating subjects exposed to nerve agents with dantrolene, or a pharmaceutically acceptable salt thereof.
• US8962841B2
  申请人：——

  公开号：US8962841B2

  公开（公告）日：2015-02-24